|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/137 | (2006.01) |
| A61K 31/485 | (2006.01) | ||
| A61K 9/20 | (2006.01) | ||
| G01G 19/414 | (2006.01) | ||
| G09B 5/06 | (2006.01) | ||
| G09B 19/00 | (2006.01) | ||
| A61P 3/04 | (2006.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 9/04 | (2006.01) | ||
| A61P 9/10 | (2006.01) |
| (11) | Number of the document | 2858640 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13800883.4 |
| Date of filing the European patent application | 2013-06-05 | |
| (97) | Date of publication of the European application | 2015-04-15 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-25 |
| (46) | Date of publication of the claims translation | 2020-08-10 |
| (86) | Number | PCT/US2013/044368 |
| Date | 2013-06-05 |
| (87) | Number | WO 2013/184837 |
| Date | 2013-12-12 |
| (30) | Number | Date | Country code |
| 201261656451 P | 2012-06-06 | US |
| (72) |
KLASSEN, Preston, US
TAYLOR, Kristin, US
|
| (73) |
Nalpropion Pharmaceuticals LLC,
10 North Place Park, Suite 201, Morristown, NJ 07960,
US
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kompozicija, skirta panaudoti pacientų su aukšta širdies ir kraujagyslių ligų rizika antsvorio ir nutukimo gydymo būde |
| Composition for use in a method of treating overweight and obesity in patients with high cardiovascular risk |
| Payment date | Validity (years) | Amount | |
| 2025-04-24 | 13 | 289.00 EUR |
| 2026-06-05 |